TuHURA Biosciences (HURA) Other Operating Expenses (2010 - 2025)
TuHURA Biosciences (HURA) posted quarterly Other Operating Expenses of $3.7 million for Q4 2025, up 7409.42% quarter-over-quarter from $49000.0 in Q3 2024.
TuHURA Biosciences (HURA) Other Operating Expenses (2010 - 2025) Analysis & Trends
TuHURA Biosciences' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $3.7 million for Q4 2025.
- In Q4 2025, Other Operating Expenses changed N/A year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 180.75% YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
- Other Operating Expenses for Q4 2025 stood at $3.7 million, up from $49000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $3.7 million in Q4 2025, with the low at -$4.6 million in Q2 2024.
- The 5-year median for Other Operating Expenses is $4000.0 (2023), against an average of -$44542.4.
- The sharpest annual moves came in 2021 and 2022: Other Operating Expenses sank 700.0% in 2021, then soared 4400.0% in 2022.
- TuHURA Biosciences' Other Operating Expenses stood at $1000.0 in 2021, then jumped by 4400.0% to $45000.0 in 2022, then sank by 91.11% to $4000.0 in 2023, then jumped by 1125.0% to $49000.0 in 2024, then jumped by 7409.42% to $3.7 million in 2025.
- Business Quant data shows HURA's Other Operating Expenses at $3.7 million in Q4 2025, $49000.0 in Q3 2024, and -$4.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | -4.61 Mn |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | -7,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 28,000.00 |